Nvidia’s earnings aren’t good enough for Wall Street… is a 50-basis-point hike coming?… where Eric Fry is looking outside AI… Luke Lango’s new non-AI picks
As I write on Wednesday, Nvidia (NVDA) is down more than 2.5% despite a strong earnings report last night that, in my opinion, provided bears zero fresh ammunition for today’s selloff.
The results were strong across the board…
In its first report since Jensen Huang’s abrupt resignation, Nvidia earned an adjusted $2.68 per share on revenue of $115.8 billion, topping Wall Street’s estimates of $2.48 and $109.1 billion, according to LSEG. Revenue more than doubled from $57 billion a year ago, and data center sales, the heart of the business, climbed 110% to $107.6 billion.
The outlook was even better…
Nvidia expects about $130 billion in revenue this quarter, well above the $125.1 billion analysts had projected. And interim CEO Colette Kress raised the company’s growth forecast for the fiscal year ending in January 2028 from 70% to 75%, answering one of the biggest questions heading into the call: whether new leadership would back away from the old forecast.
Plus, these numbers apparently hold up without China. After Monday’s Commerce Department move to block Nvidia chips from being rented to Chinese companies, Nvidia said its outlook assumes no data center compute revenue from China.
The second question heading into last night was whether Nvidia would continue in its role as the “central bank of AI”
Over the past year, Nvidia has provided backstops to emerging AI companies and lent its balance sheet to support data-center debt, and investors worried a chastened Nvidia would pull back.
Last night, we learned that the checkbook isn’t closing, but it’s no longer open-ended.
Kress stated that Nvidia is “rigorously evaluating” future deals to finance or backstop customers, and that it will remain “disciplined and selective in our support” of neoclouds.
She went on to say:
We do have some very, very strong existing customers that we will be continuing to work with.
Overall, legendary investor Louis Navellier, a longtime NVDA bull, summed it up: “Everything’s fine with Nvidia.”
Here’s more from this morning’s Prime Portfolio Flash Alert podcast:
Nothing has changed. Nvidia’s stronger than ever…
The AI boom is still very much intact. At the same time, valuations across many growth stocks have been compressed to extremely low levels… That combination could set the stage for a very strong rebound.
So, everything’s fine folks. You’re going to enjoy the holidays. We’re all going to have great Thanksgiving and we’re going to grow and prosper.
While we might be in for a rally, the market remains unconvinced as I write
Wall Street has already jumped ahead to the next thing to worry about – a potential 50-basis-point rate hike next month thanks to fresh hawkish Fed talk.
Here’s Federal Reserve Governor Christopher Waller speaking on CNBC this morning:
I’m very, very concerned about inflation. It’s kind of headed in the wrong direction, and it’s spreading out. If you really want to get it down, you’ve got to start taking more aggressive actions.
You might need to, like, shock people.
This comes after comments yesterday from St. Louis Fed President Alberto Musalem that pointed toward four hikes – potentially by early next year.
From his speech Tuesday in Argentina:
The economy will likely require several interest rate increases before the spring of 2027 to achieve 2% inflation in a timely manner.
As I write, Wall Street is latching onto the latest reason to sell rather than feeling emboldened by Nvidia’s strong numbers.
So, where does this leave us?
Nvidia helped the AI trade last night. It gave the bulls something to cheer after a brutal stretch, but this morning showed how fragile the relief is.
So, while we hope this is still the start of a very strong rebound per Louis, let’s do something productive to insulate us if it’s not…
Look at specific ways to diversify away from the AI trade, courtesy of two of our experts.
We’ll do it in two steps: first, how to separate the sturdier AI holdings from the shakier ones, and then how to put some money to work outside AI entirely.
Let’s start with Eric Fry, who has been focused on the question beneath the scandal.
Diversifying starts inside AI: Eric’s two-group test
Eric, our global macro expert and editor of Fry’s Investment Report, thinks the most important piece of this story isn’t who runs Nvidia next – it’s whether the AI sector financing continues:
The heart of this salacious story is not, “Who will replace Jensen Huang?” but rather, “Who will replace the credit line Nvidia extended to the entire AI ecosystem?”
Last night’s earnings call suggests that Nvidia’s credit line is still open – though perhaps not to the degree as before. And that could be significant for many companies that came to rely on that funding.
Back to Eric for a reminder about the scope of the lending:
Over the past year, Nvidia took part in a record 129 venture capital deals, up from 49 in 2023, and accounted for 27% of global venture capital deal value, the WSJ reports.
UBS analyst Tim Arcuri estimates that an Nvidia pullback could drain $50 billion or more from the market.
To whatever degree Nvidia slows down, replacing that amount of lending won’t be cheap.
The 10-year Treasury yield is above 5% – and, as we saw a moment ago, some Fed members appear ready to vote for a jumbo hike.
Meanwhile, CNBC reported earlier this month that the unsecured bonds of CoreWeave (CRWV), one of the “neocloud” companies that rent out Nvidia’s chips, topped a 16% yield. That’s what lenders demand when they’re nervous.
So, how do you invest in a world where the AI credit line may be shrinking?
Here’s how Eric is sorting the landscape:
I’m sorting AI holdings into two groups:
Self-funders. These companies pay for their buildout from operating cash flow. They may borrow, but they don’t need to. If credit tightens, they slow down; they don’t go under. Some may even benefit as weaker rivals cancel orders and sell assets at distressed prices.
Dependents. These companies rely on someone else’s assistance — a vendor’s equity stake, a loan guarantee, or a bond market that stays open. Heavy debt, a handful of customers, and a business model that works only if the next financing round closes on time: those are the warning signs.
Notice that the test isn’t how good a company is at AI. It’s whether that company can pay for its own ambitions if the lending stops.
To keep score, Eric is watching three data points over the coming months: whether Nvidia changes its language about “strategic investments”; whether Nvidia renews, trims, or quietly allows any of its existing commitments to lapse; and whether the bond prices of CoreWeave and Oracle (ORCL) continue falling.
Here’s Eric’s overall bottom line:
The question that matters for your portfolio is who will replace the credit line [Huang] extended to the entire AI ecosystem.
Want to diversify beyond AI while you wait for the rebound?
Consider solar.
This is what Eric is doing – he just added a new turnaround play in the solar sector to the Fry’s Investment Report model portfolio.
The stock is down more than 60% from its mid-2023 level, but the underlying business is now strengthening. The company just posted record revenue growth, up 44% from a year earlier, alongside a big jump in margins.
Plus, Eric believes the tailwinds will only pick up from here, and the midterms are a big reason why. Democrats swept both chambers of Congress, and with both in hand, they will likely push to extend the business solar tax credits beyond 2027, when they’re currently scheduled to wind down.
To be fair, any extension would still need President Trump’s signature, so this is a shift in the odds rather than a done deal. But Eric believes the potential reward outweighs the risks.
I won’t reveal the name out of respect for Eric’s subscribers, but to join them in Fry’s Investment Report and get all the details, click here to learn more.
In the meantime, if you want a one-click way to play the solar theme, there’s the Invesco Solar ETF (TAN). It holds roughly three dozen solar companies.
And if you want even more solar analysis, our Editor-in-Chief and co-Digest writer Luis Hernandez recently sat down with Eric and veteran trader Jonathan Rose, editor of Masters in Trading Live, to discuss the opportunity in solar.
We just profiled Eric’s interest, but Jonathan was drawn to it for different reasons. He follows the money, watching for unusual options activity that suggests big players are positioning ahead of a move. After the midterms, traders piled into more than 12,500 contracts of the TAN call option, up from fewer than 500 already open.
In the video chat, Jonathan explains how he reads unusual options activity and what it’s telling him right now, and Eric walks through his specific case for the solar trade.
Click the play button below to watch the full conversation.
Luke Lango’s pivot away from AI
Eric isn’t the only one looking beyond AI infrastructure.
Luke Lango, editor of Innovation Investor, has long been one of our most committed technology bulls, but as he evaluates today’s market, he sees strength beyond AI.
Here he is from Monday’s Innovation Investor Daily Notes:
There are pockets of strength elsewhere in the market, like healthcare, shipping and some software stocks, and we plan to play offense there while the AI trade stalls out…
Luke has already pulled the trigger over the last week. Monday brought two of his latest new buys in Innovation Investor. Here’s how he framed the setup:
Being defensive on AI infrastructure doesn’t mean being defensive everywhere…
A handful of stocks with little to no exposure to spending by the biggest cloud companies are breaking higher on strong earnings.
Those are the stocks we want to own right now: strong business results, strong charts, and no dependence on those companies’ spending plans.
One of the buys is a health services company that benefits from an aging population and the steady shift of complex care out of hospitals and into the home.
If this sounds familiar, it’s because Eric has been all over the growing number of opportunities in health care for months (one of his latest picks is Novo Nordisk A/S (NVO), which we covered in our Sept. 30 Digest here).
Once again, I’ll save the specific name for Luke’s subscribers – you can learn more about joining him in Innovation Investor here – but to piggyback on his broader analysis, there are plenty of healthcare ETFs to consider.
Check out the iShares U.S. Healthcare ETF (IYH), which focuses on U.S. equities across pharmaceuticals, biotechnology, and equipment. It’s heavily weighted toward top drug makers like Eli Lilly (LLY) and Johnson & Johnson (JNJ).
If you don’t like market-cap weighting, there’s the Invesco S&P 500 Equal Weight Health Care ETF (RSPH), which equal-weights the sector’s S&P 500 constituents to reduce over-concentration in mega-cap giants. Its holdings include healthcare names such as DaVita (DVA) and Universal Health Services (UHS), which are closer to the kind of business Luke just bought.
Wrapping up
Coming full circle, Nvidia gave Wall Street great numbers last night, but this morning showed how fragile that relief can be.
Whether the rally returns or stalls, the lesson of the past month is the same: don’t let one theme, however exciting, carry your entire portfolio.
Have a good evening,
Jeff Remsburg
P.S. Today is the last day to watch the free replay of Louis’ Fed Warning 2027 presentation
During it, he unveiled his new Prime Portfolio. It’s 25 of Louis’ strongest recommendations from across his research services – the “crème de la crème” as he puts it. Every month, he reassesses the lineup, rotating out stocks that no longer meet his standards and replacing them with stronger opportunities.
Watch the replay here to get all the details before we take it down tonight.